SC
CVS icon

Stolper & Co’s CVS Health CVS Stock Holding History

Stolper & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86M Sell
27,604
-77,967
-74% -$6.96M 0.74% 40
2026
Q1 		$8.03M Buy
105,571
+78,765
+294% +$6.07M 2.28% 18
2025
Q4 		$2.13M Buy
26,806
+923
+4% +$72.8K 0.63% 48
2025
Q3 		$1.95M Buy
25,883
+1,061
+4% +$72.7K 0.59% 54
2025
Q2 		$1.71M Buy
24,822
+24
+0.1% +$1.57K 0.56% 55
2025
Q1 		$1.68M Buy
24,798
+3,369
+16% +$202K 0.55% 55
2024
Q4 		$962K Sell
21,429
-2,438
-10% -$137K 0.32% 61
2024
Q3 		$1.5M Buy
23,867
+151
+0.6% +$8.81K 0.49% 57
2024
Q2 		$1.4M Buy
23,716
+516
+2% +$32.3K 0.49% 58
2024
Q1 		$1.85M Buy
23,200
+849
+4% +$64.9K 0.67% 48
2023
Q4 		$1.76M Sell
22,351
-752
-3% -$53.5K 0.71% 42
2023
Q3 		$1.61M Buy
23,103
+917
+4% +$65K 0.7% 43
2023
Q2 		$1.53M Buy
22,186
+390
+2% +$27.8K 0.65% 51
2023
Q1 		$1.62M Buy
21,796
+211
+1% +$17.7K 0.69% 50
2022
Q4 		$2.01M Sell
21,585
-4,339
-17% -$419K 0.88% 35
2022
Q3 		$2.47M Buy
25,924
+1,142
+5% +$113K 1.22% 30
2022
Q2 		$2.3M Buy
24,782
+792
+3% +$77.3K 1.08% 34
2022
Q1 		$2.43M Buy
23,990
+538
+2% +$56.5K 1.03% 32
2021
Q4 		$2.42M Sell
23,452
-127
-0.5% -$11.7K 1.08% 30
2021
Q3 		$2M Buy
23,579
+227
+1% +$19K 0.96% 32
2021
Q2 		$1.95M Buy
23,352
+166
+0.7% +$13.6K 0.92% 32
2021
Q1 		$1.74M Sell
23,186
-116
-0.5% -$8.45K 0.9% 34
2020
Q4 		$1.59M Buy
23,302
+447
+2% +$29.1K 0.89% 36
2020
Q3 		$1.33M Sell
22,855
-3,296
-13% -$205K 0.86% 38
2020
Q2 		$1.7M Sell
26,151
-1,983
-7% -$125K 1.11% 32
2020
Q1 		$1.67M Buy
+28,134
New +$1.88M 1.2% 30

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.99B AUM 86.33% 1-Year Est. Return

Stolper & Co's CVS Position: Q2 2026 in Review

Stolper & Co reduced its CVS Health (CVS) stake by 74% in Q2 2026, selling an estimated $6.96M and leaving 27,604 shares worth $2.86M. The position accounts for 0.74% of the portfolio, ranked #40.

Stolper & Co first reported a position in CVS in Q1 2020 and has held it in 26 quarters since. The position peaked at $8.03M in Q1 2026. 399 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Stolper & Co held 27,604 shares of CVS Health worth $2.86M as of Q2 2026.
  • Stolper & Co sold 77,967 CVS Health shares in Q2 2026, an estimated $6.96M.
  • CVS Health made up 0.74% of Stolper & Co's portfolio in Q2 2026, its #40 holding.
  • Stolper & Co first reported a position in CVS Health in Q1 2020 and has held it in 26 quarters since.
  • Stolper & Co's CVS Health position peaked at $8.03M in Q1 2026.
  • 399 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Stolper & Co's 13F filing for Q2 2026, filed 14 Jul 2026.